CD40 (protein): Difference between revisions
CSV import |
No edit summary |
||
| Line 33: | Line 33: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 16:50, 22 March 2025
CD40 is a protein that is encoded by the CD40 gene in humans. It is a member of the TNF-receptor superfamily. This protein is expressed on the surface of B cells, dendritic cells, monocytes, thymocytes, and endothelial cells. It plays a crucial role in B-cell activation and differentiation, and also has important functions in the immune response to T cells.
Structure[edit]
The CD40 protein is a 277-amino acid transmembrane protein. It is composed of an extracellular domain, a transmembrane domain, and a cytoplasmic domain. The extracellular domain contains the binding site for the CD40 ligand, while the cytoplasmic domain is responsible for transmitting the signal into the cell.
Function[edit]
CD40 is a receptor that plays a vital role in the activation and differentiation of B cells. When CD40 is bound by its ligand, CD40L, it triggers a series of intracellular events that lead to B cell activation and differentiation. This process is crucial for the production of antibodies and the development of memory B cells.
In addition to its role in B cells, CD40 also has important functions in other immune cells. In dendritic cells, CD40 signaling can lead to the production of cytokines and the upregulation of co-stimulatory molecules, which are important for T cell activation. In monocytes, CD40 signaling can induce the production of pro-inflammatory cytokines and chemokines.
Clinical significance[edit]
Alterations in the CD40 pathway have been implicated in a number of diseases, including autoimmune diseases, cancer, and infectious diseases. For example, mutations in the CD40 gene have been associated with hyper IgM syndrome, a rare immunodeficiency characterized by a lack of IgG and IgA antibodies.
In cancer, CD40 signaling can have both pro-tumor and anti-tumor effects. On one hand, CD40 signaling can promote tumor growth by stimulating the production of pro-inflammatory cytokines that support tumor growth. On the other hand, CD40 signaling can also stimulate anti-tumor immune responses by activating dendritic cells and T cells.
See also[edit]
References[edit]
<references />
